Evidence map›Paper›PMID 39315598›Full record

ArticleCancer medicine2024

Clinician perceptions on barriers and facilitators to 1-year surveillance colonoscopy completion in survivors of colorectal cancer.

C Natasha Kwendakwema, Talor Hopkins, Ari Bell-Brown, Vlad V Simianu, Veena Shankaran, Rachel B Issaka

Abstract read
In one paragraph

Article in Cancer medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

C Natasha KwendakwemaHutchinson Institute for Cancer Outcomes Research, Fred Hutch Cancer Center, Seattle, Washington, USA.ORCID https://orcid.org/0000-0003-2642-1690
Talor HopkinsHutchinson Institute for Cancer Outcomes Research, Fred Hutch Cancer Center, Seattle, Washington, USA.
Ari Bell-BrownHutchinson Institute for Cancer Outcomes Research, Fred Hutch Cancer Center, Seattle, Washington, USA.
Vlad V SimianuCenter for Digestive Health, Virginia Mason Franciscan Health, Seattle, Washington, USA.
Veena ShankaranHutchinson Institute for Cancer Outcomes Research, Fred Hutch Cancer Center, Seattle, Washington, USA.
Rachel B IssakaHutchinson Institute for Cancer Outcomes Research, Fred Hutch Cancer Center, Seattle, Washington, USA.

Funding

Translational Bioimaging Core Shared ResourceP30CA015704 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Eric Collisson · 1985 to 2026
$296.4M
TRAINING IN CANCER BIOLOGY &TRANSPLANTATIONT32CA009515 · NCI · UNIVERSITY OF WASHINGTON · PI NANCY ELLEN DAVIDSON, Effie W Petersdorf · 1985 to 2026
$16.2M
Developing an intervention to improve follow-up of abnormal fecal immunochemical test results in a safety-net population using a mixed methods approachK08CA241296 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI ISSAKA, RACHEL B. · 2019 to 2023
$1.1M
CCR NIH HHS K08CA241296CCR NIH HHS P30 CA015704NCI NIH HHS K08 CA241296NCI NIH HHS P30 CA015704NCI NIH HHS T32 CA009515NCI NIH HHS T32CA009515
6 · The paper itself

Abstract

introductionColorectal cancer (CRC) is the second leading cause of cancer deaths in the United States. Surveillance colonoscopy is recommended 1-year after surgical resection for patients with stage I-III CRC; however, only 18%-61% of CRC survivors complete this test. This study describes clinician-identified barriers and facilitators to surveillance colonoscopy among CRC survivors.

methodsWe conducted semi-structured interviews with clinicians until thematic saturation was achieved. Interviews were analyzed using the social cognitive theory.

resultsThirteen clinicians were interviewed, and all identified health system-level barriers to surveillance colonoscopy completion; the most common being fragmented care due to patients receiving care across many health systems. Clinicians also identified social determinants of health barriers (e.g., geographical distance between patients and health systems) to 1-year surveillance colonoscopy completion.

conclusionsClinicians identified several potentially modifiable barriers to 1-year surveillance colonoscopy completion which, if addressed, could improve post-treatment care and outcomes among stage I-III CRC survivors.

Indexed as

Cancer SurvivorsColonoscopyColorectal NeoplasmsAttitude of Health PersonnelEarly Detection of CancerFemaleHealth Services AccessibilityHumansMaleMiddle Agedbarrierscolonoscopycolorectal cancerfacilitatorssurveillance

Identifiers

PMID39315598
PMCPMC11420656

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.